Revvity ROE 2010-2025 | RVTY
Current and historical return on equity (ROE) values for Revvity (RVTY) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Revvity ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-06-30 | $0.29B | $7.56B | 3.70% |
| 2025-03-31 | $0.29B | $7.64B | 3.68% |
| 2024-12-31 | $0.27B | $7.67B | 3.45% |
| 2024-09-30 | $0.25B | $7.92B | 3.22% |
| 2024-06-30 | $0.17B | $7.87B | 2.16% |
| 2024-03-31 | $0.15B | $7.85B | 1.92% |
| 2023-12-31 | $0.69B | $7.87B | 8.81% |
| 2023-09-30 | $0.74B | $7.69B | 9.58% |
| 2023-06-30 | $0.82B | $7.87B | 10.78% |
| 2023-03-31 | $0.96B | $8.03B | 12.97% |
| 2022-12-31 | $0.57B | $7.38B | 7.90% |
| 2022-09-30 | $0.63B | $7.07B | 8.84% |
| 2022-06-30 | $0.67B | $7.17B | 9.48% |
| 2022-03-31 | $0.74B | $7.19B | 11.61% |
| 2021-12-31 | $0.94B | $7.14B | 16.88% |
| 2021-09-30 | $1.13B | $6.96B | 23.93% |
| 2021-06-30 | $1.18B | $4.24B | 31.09% |
| 2021-03-31 | $1.07B | $4.00B | 30.80% |
| 2020-12-31 | $0.73B | $3.74B | 22.94% |
| 2020-09-30 | $0.41B | $3.23B | 14.03% |
| 2020-06-30 | $0.30B | $2.97B | 10.49% |
| 2020-03-31 | $0.23B | $2.76B | 8.26% |
| 2019-12-31 | $0.23B | $2.81B | 8.39% |
| 2019-09-30 | $0.23B | $2.71B | 8.80% |
| 2019-06-30 | $0.25B | $2.71B | 9.60% |
| 2019-03-31 | $0.25B | $2.64B | 9.58% |
| 2018-12-31 | $0.24B | $2.59B | 9.31% |
| 2018-09-30 | $0.13B | $2.57B | 4.97% |
| 2018-06-30 | $0.14B | $2.52B | 5.54% |
| 2018-03-31 | $0.28B | $2.56B | 11.16% |
| 2017-12-31 | $0.29B | $2.50B | 12.10% |
| 2017-09-30 | $0.40B | $2.54B | 17.09% |
| 2017-06-30 | $0.37B | $2.44B | 16.38% |
| 2017-03-31 | $0.23B | $2.21B | 10.53% |
| 2016-12-31 | $0.23B | $2.15B | 11.11% |
| 2016-09-30 | $0.24B | $2.14B | 11.31% |
| 2016-06-30 | $0.23B | $2.09B | 11.28% |
| 2016-03-31 | $0.22B | $2.05B | 10.51% |
| 2015-12-31 | $0.21B | $2.11B | 10.16% |
| 2015-09-30 | $0.18B | $2.05B | 8.46% |
| 2015-06-30 | $0.16B | $2.12B | 7.82% |
| 2015-03-31 | $0.16B | $2.06B | 7.93% |
| 2014-12-31 | $0.16B | $2.04B | 7.67% |
| 2014-09-30 | $0.19B | $2.06B | 9.48% |
| 2014-06-30 | $0.19B | $2.06B | 9.55% |
| 2014-03-31 | $0.17B | $2.03B | 8.66% |
| 2013-12-31 | $0.17B | $1.99B | 8.78% |
| 2013-09-30 | $0.08B | $1.92B | 4.45% |
| 2013-06-30 | $0.07B | $1.86B | 3.91% |
| 2013-03-31 | $0.08B | $1.83B | 4.21% |
| 2012-12-31 | $0.07B | $1.94B | 3.71% |
| 2012-09-30 | $0.00B | $1.94B | 0.16% |
| 2012-06-30 | $0.01B | $1.89B | 0.53% |
| 2012-03-31 | $0.01B | $1.88B | 0.31% |
| 2011-12-31 | $0.01B | $1.84B | 0.42% |
| 2011-09-30 | $0.39B | $1.95B | 20.07% |
| 2011-06-30 | $0.36B | $1.96B | 19.42% |
| 2011-03-31 | $0.39B | $1.91B | 21.83% |
| 2010-12-31 | $0.39B | $1.93B | 22.64% |
| 2010-09-30 | $0.13B | $1.71B | 7.93% |
| 2010-06-30 | $0.13B | $1.64B | 8.12% |
| 2010-03-31 | $0.10B | $1.63B | 5.97% |
| 2009-12-31 | $0.08B | $1.63B | 5.26% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $10.644B | $2.755B |
| Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $151.373B | 28.07 |
| CVS Health (CVS) | United States | $89.823B | 11.17 |
| Elevance Health (ELV) | United States | $69.805B | 9.39 |
| Cencora (COR) | United States | $58.879B | 19.61 |
| DiDi Global (DIDIY) | China | $28.380B | 30.15 |
| Labcorp Holdings (LH) | United States | $23.110B | 18.37 |
| Natera (NTRA) | United States | $22.048B | 0.00 |
| BioMerieux (BMXMF) | France | $17.636B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.729B | 0.00 |
| ICON (ICLR) | Ireland | $14.556B | 14.01 |
| Medpace Holdings (MEDP) | United States | $13.083B | 34.63 |
| Solventum (SOLV) | United States | $12.631B | 13.03 |
| CochLear (CHEOY) | Australia | $12.527B | 0.00 |
| Viatris (VTRS) | United States | $12.417B | 4.42 |
| Caris Life Sciences,�Inc (CAI) | United States | $9.863B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $9.237B | 0.00 |
| Avantor (AVTR) | United States | $8.781B | 12.88 |
| Charles River Laboratories (CRL) | United States | $7.854B | 14.90 |
| HealthEquity (HQY) | United States | $7.700B | 33.73 |
| Bausch + Lomb (BLCO) | Canada | $5.147B | 34.62 |
| Sotera Health (SHC) | United States | $4.630B | 25.87 |
| BrightSpring Health Services (BTSG) | United States | $4.186B | 31.93 |
| Amplifon S.p.A (AMFPF) | Italy | $3.937B | 21.83 |
| GeneDx Holdings (WGS) | United States | $3.455B | 79.14 |
| Surgery Partners (SGRY) | United States | $3.057B | 38.45 |
| Alignment Healthcare (ALHC) | United States | $2.974B | 0.00 |
| Concentras Parent (CON) | United States | $2.966B | 18.81 |
| Organon (OGN) | United States | $2.436B | 2.65 |
| Premier (PINC) | United States | $2.104B | 19.50 |
| Progyny (PGNY) | United States | $1.940B | 41.02 |
| Ardent Health (ARDT) | United States | $1.863B | 7.19 |
| PACS (PACS) | United States | $1.817B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.518B | 25.71 |
| Pediatrix Medical (MD) | United States | $1.417B | 9.46 |
| Teladoc Health (TDOC) | United States | $1.276B | 0.00 |
| Omada Health (OMDA) | $1.240B | 0.00 | |
| Establishment Labs Holdings (ESTA) | $1.132B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.962B | 0.00 |
| Embecta (EMBC) | United States | $0.812B | 4.76 |
| AMN Healthcare Services Inc (AMN) | United States | $0.778B | 9.62 |
| CareDx (CDNA) | United States | $0.648B | 11.93 |
| Performant Healthcare (PHLT) | United States | $0.602B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.598B | 102.50 |
| Nutex Health (NUTX) | United States | $0.515B | 7.80 |
| Agilon Health (AGL) | United States | $0.501B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.482B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.471B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.467B | 7.01 |
| SBC Medicals (SBC) | United States | $0.413B | 9.07 |
| So-Young (SY) | China | $0.412B | 0.00 |
| Enhabit (EHAB) | United States | $0.411B | 27.03 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.391B | 0.00 |
| Oncology Institute (TOI) | United States | $0.334B | 0.00 |
| LifeMD (LFMD) | United States | $0.294B | 0.00 |
| Beauty Health (SKIN) | United States | $0.269B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.184B | 0.00 |
| DocGo (DCGO) | United States | $0.157B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.116B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.085B | 0.00 |
| KindlyMD (NAKA) | United States | $0.076B | 0.00 |
| Biodesix (BDSX) | United States | $0.060B | 0.00 |
| NeueHealth (NEUE) | United States | $0.059B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.050B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.038B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.036B | 0.00 |
| ModivCare (MODV) | United States | $0.027B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.022B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.011B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.011B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |